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Background
Tuberculosis (TB) is considered as one of the major public health 
problems in developing countries, with an estimated 8.7 million 
new cases worldwide annually (1). In 2012, the incidence rate 
of TB was 14.4 per 100000 people in Iran (2). Out of 10987 
TB registered cases 5386 cases, (49%) had smear-positive 
pulmonary TB (2). The TB case detection rate in Iran was also 
below the global TB control target of 84% (3). Spreading of TB 
is accompanied by several epidemiological factors, notably the 
HIV/AIDS epidemic, low socio-economic status, overcrowding 
and malnutrition (1,4).
Among the 22 countries that, together, account for 80% of all 
TB cases worldwide, Asian countries such as Afghanistan and 
Pakistan, the neighbor countries of Iran, are heavily affected by 
TB (5). This issue intensifies the problem of TB prevention in 
Iran.
Several studies have been conducted to investigate pulmonary 
TB and its different aspects. The current evidence suggests 
that numerous factors have effect on pulmonary TB such as 
drug resistance pattern, diagnosis delay, pattern of reported 
TB cases (6–8). With regards to demographic factors which 
include ethnicity and gender; for example, a study conducted 
in southern Iran reported that Afghan immigrants were at high 
risk for TB infected and women were also more affected (9).
It is not possible to conduct a suitable program without sound 
evidence on epidemiology status of TB disease. Epidemiological 
information on TB is required to plan control and prevention 
strategies and to inform service delivery systems. Assessment 
of the epidemiological indices within a specific time period 
can also help planners to focus on the main problems of a 
community and to assess the efficacy of preventive programs. 
Given the reasons provided, the aim of present study was 
to determine the epidemiological status of TB in Hamadan 
Province covering a seven-year period.
Methods
This cross-sectional study was conducted in Hamadan 
Province, western Iran, in 2012. The total area of Hamadan 
Province is 19546 Km2, with a population of over 1.7 million 
(2006 population census).
In this survey all registered TB patients suffering from any form 
of smear-positive, smear-negative or extra pulmonary from 
2005 to 2011 (seven years) in all parts of Hamadan Province 
were assessed. TB cases were defined according to World Health 
Organisation (WHO) and Iran’s national TB guideline (10). The 
Afghan immigrants, patients with wrong diagnosis and non-
native born citizen patients were excluded from the study.
The available data were extracted from the National TB Program 
(NTP) using a checklist of items including demographic 
characteristics of the TB patients such as gender, age, time of 
diagnosis, source of reporting (public health system, private 
health system, Social Security Organization, other), history of 
hospitalization for TB (yes, no, unknown), recent close contact 
with TB patient (yes, no, unknown), group classification (new 
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case, relapse, other), result of treatment (cured,  and other--
including: death, treatment failure, transfer out and unknown), 
place of residence (urban and rural), history of jailed (yes, no, 
or no data), HIV status (positive, negative, or no data), and 
type of TB (positive, negative, extra pulmonary). These data 
were obtained at the time of diagnosis and recorded in the TB 
register software.
For data analysis we used descriptive statistics including 
frequency tables, measures of central value and measures of 
dispersion to describe the study variables. Age-adjusted trend 
and incidence of all TB cases, smear-positive and negative 
pulmonary TB were analyzed during 2005–11. The Cochran-
Armitage (C-A) test was employed to test the trends over time. 
To adjust for age, direct age adjustment was done by applying 
the population from 2005 as reference population.
To determine the annual rate of percent change in TB incidence 
during 2005–11, we also used the following formula:
100incidence rateof final year incidence rateof initial year
number of years
−
×
The sources of TB reporting (five levels) with dichotomous 
variables were compared using the Chi-square test. In so 
doing, the level of “other” was excluded as 75% of TB reported 
cased were unknown. All the data were analyzed by Stata 11 
(StataCorp LP, College Station, TX, USA).
Results
Of 623 registered TB patients during 2005–11, 26 cases were 
excluded due to exclusion criteria (Figure 1). Thus, a total of 597 
patients are presented in this study. Table 1 shows distribution 
of characteristics of registered TB patients between 2005 and 
2011.
The mean age of TB patients was 57.0 (SD ± 21.1), 49.9% were 
males (the male-to-female ratio was 1.00), 52.7% were aged 61 
years or older and 39.7% were rural. Previous history of jailed 
was present in 13 (2.2%) patients and 12 (2.0%) were HIV 
positive. 
From all TB patients, 60.8% were smear-positive, 87.6% were 
new cases and 87.3% of smear-positive patients were cured 
cases. Also, 23.6% of patients had history of hospitalization for 
TB. More than half (55.4%) of TB patients were reported by 
public health system (Table 2).
Age-adjusted incidence and trends of TB case-finding are 
presented in Table 3. Compared with case reporting in 2005, 
reporting during the study period was significantly higher, 
rising from 115 expected number of cases to 252, annual rate 
of change: 56%, (C-A trend test, P< 0.001), particularly for new 
pulmonary smear-negative cases. Age-adjusted incidence of 
all TB cases during 2005–11 was 3.4, 3.2, 3.6, 4.7, 3.3, 4.4 and 
7.3 in 100,000 respectively (C-A trend test, P< 0.001). The age-
adjusted prevalence of TB cases increased from 4.1 in 100,000; 
in 2005 to 8.5 in 100,000; in 2011 (C-A test, P< 0.001).
The majority of reported TB cases in private clinics were aged 
61 or older (54.0%) and female (60.5%) compared with public 
outpatient services (P= 0.029). Of the 215 reported cases of 
TB by public hospitals, 111 cases (51.6%) were male and 104 
(48.4%) were female. However, the number of reported TB 
Figure 1. Algorithm of the study design
Sources of TB Reporting
Public health systems
          (n= 341)
Private health system
          (n= 91)
Social Security
 organization  (n= 21)
   Other 
 ( n= 170)
National TB Program (n= 623)
Exclusion criteria: Afghan patients (n= 11), Non-native born citizens (n= 2), 
Wrong diagnosis (n= 13)
Total Patients (n= 597)
Year 2005 Year 2006 Year 2007 Year 2008 Year 2009 Year 2010 Year 2011
Population:
  1669870
Incidence Cases:
      57
Old Cases:
      11
Population:
  1703267
Incidence Cases:
      55
Old Cases:
      6
Population:
  1711783
Incidence Cases:
      61
Old Cases:
      12
population:
  1720342
Incidence Cases:
      81
Old Cases:
      7
Population:
  1728944
Incidence Cases:
      57
Old Cases:
      7
Population:
  1669870
Incidence Cases:
      77
Old Cases:
      9
Population:
  1758268
Incidence Cases:
      135
Old Cases:
      22
Direct Age Adjustment
Year 2005 Year 2006 Year 2007 Year 2008 Year 2009 Year 2010 Year 2011
 Standard
Population:
  3373120
 Expected
incidence Cases:
       115
 Expected
 prevalence
 of cases:
      137
 Standard
Population:
  3426022
 Expected
incidence Cases:
       252
 Expected
 prevalence
 of cases:
      292
 Standard
Population:
  3307438
 Expected
incidence Cases:
       151
 Expected
 prevalence
 of cases:
      169
 Standard
Population:
  3398796
 Expected
incidence Cases:
       112
 Expected
 prevalence
 of cases:
      126
 Standard
Population:
  3390194
 Expected
incidence Cases:
       160
 Expected
 prevalence
 of cases:
      173
 Standard
Population:
  3381633
 Expected
incidence Cases:
       121
Expected
 prevalence
 of cases:
      144
 Standard
Population:
  3373120
 Expected
incidence Cases:
       109
 Expected
 prevalence
 of cases:
      121
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cases in males was more than females. But, this proportion 
was no significant (P= 0.103). In contrast, older TB cases were 
significantly higher in public hospitals than public outpatient 
services (70.2 vs. 29.8, P= 0.03; Table 4). Of the 116 TB reported 
cases by public outpatient services compared with public 
hospitals, 79 cases (76.7%) were smear-negative TB and extra 
pulmonary and 23.3% were smear-positive (P< 0.001). In all, 
from 428 TB reported cases, 50.2% reported by public hospitals.
Discussion
The TB incidence is one of the most important surveillance 
indicators in public health. Although incidence and mortality 
of TB is declining globally except in Sub-Saharan Africa (11), 
but the results of present study revealed significant increase 
in the incidence rate of all TB classifications (56%, P< 0.001), 
especially in the incidence rate of new smear-negative 
pulmonary TB (30%) in the 2005–11 period. A similar study 
conducted by Salek et al. (12), to evaluate the alterations of TB 
epidemiologic indices in Golestan Province, demonstrated that 
only incidence of smear-negative pulmonary TB has changed 
significantly during the study period. According to Center for 
Iranian Disease Control and Prevention report, the incidence 
Table 1. Characteristics of registered TB patients in Hamadan province, 
Iran, 2005–11
Variables Number %
Gender
Male 298 49.9
Female 299 50.1
Age group
0–30 year 93 15.6
31–60 year 189 31.7
+61 year 315 52.7
Place of residence
Urban 360 60.3
Rural 237 39.7
HIV status
Positive 12 2.0
Negative 32 5.4
Unknown 553 92.6
Type of TB
Positive 363 60.8
Negative 113 18.9
Extra pulmonary 121 20.3
Group Classification
New case 523 87.6
Relapse 25 4.2
Other 49 8.2
Result of treatment (Smear-positive= 363)
Cured 317 87.3
Othera 46 12.7
Result of treatment (Smear-negative & Extra pulmonary= 234)
Treatment completed 165 70.5
Other 69 29.5
History of jailed
Yes 13 2.2
No 552 97.8
History of hospitalization
Yes 141 23.6
No 329 55.1
Unknown 127 21.3
aOther: Death, Treatment failure, Transfer out, and Unknown. rate of TB in Iran has shown a descending trend during past 
decades (142 in 100000 in 1964 to 14.4 in 100000 in 2012) (2). 
Nevertheless, the prevalence of HIV/AIDS in Iran has changed 
from low to concentrate phase and the estimated number of 
infected people with HIV by 2014 amounts to 106000 (13). 
Several previous studies have also reported TB/HIV co-
infection; 30% in Brazil (14), 15.8% in western China (15), 42% 
in Southern Africa (16). All of these studies have revealed that 
HIV infection dramatically increases the incidence of TB (17). 
In addition, the rate of TB/HIV co-infection has been 2.4% in 
Iran in 2012 (2). We suggest that the prevalence of co-infection 
in the area under study is below the national average, and this 
might be associated with the low demand for HIV testing in the 
area, as a study performed in a neighbor province, Kurdistan 
revealed most participants (68.9%) did not undergo HIV 
testing (18). As such, people and related organizations should 
pay more attention to the problem of co-infection. Results of 
a study conducted in Congo to assess the provision of HIV/TB 
co-infection services in health facilities revealed that TB care 
was more available than HIV care and TB/HIV co-infection 
rates among patients were unknown in 82% of the facilities (19).
According to our findings, male to female ratio was 1.0 among 
TB patients, similar to the national report (11), while WHO has 
reported a male/female ratio of 1.9 for the case notification rate 
Table 2. Comparison between investigated variables and gender using 
Chi-square test
Variables Male (%) Female (%) P-value
Age group
0–30 year 36 (12.1) 57 (19.1)
<0.00131–60 year 118 (39.6) 71 (23.7)
+61 year 144 (48.3) 171 (57.2)
Place of residence
0.120Urban 189 (63.4) 171 (57.2)
Rural 109 (36.6) 128 (42.8)
Type of TB
0.414
Positive 180 (60.4) 183 (61.2)
Negative 62 (20.8) 51 (17.1)
Extra pulmonary 56 (18.8) 65 (21.7)
Group Classification
0.016
New case 250 (83.9) 273 (91.3)
Relapse 18 (6.0) 7 (2.3)
Other 30 (10.1) 19 (6.4)
Recent close contact with TB patienta
0.018Yes 28 (16.5) 48 (27.1)
No 141 (83.5) 129 (72.9)
Result of treatment (Smear-positive= 363)
0.051Cured 151 (83.9) 166 (90.7)
Otherb 29 (16.1) 17 (9.3)
Result of treatment (Smear-negative & Extr a pulmonary= 234)
0.228
Treatment 
Completed
79 (66.9) 86 (74.1)
Other 39 (33.1) 30 (25.9)
Source of reporting
0.019
Public health  
System outpatient
49 (16.4) 67 (22.4)
Public health 
System hospital
111 (37.3) 104 (34.8)
Private 30 (10.1) 46 (15.4)
Other 108 (36.2) 82 (27.4)
aUnknown information on recent close contact with TB case has deleted= 
251; bOther: Death, Treatment failure, Transfer out, and Unknown.
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worldwide (11). In addition, a multi-centre case-control study 
conducted in three West African countries found a male/female 
ratio of 2.03 among patients with TB (20). The distinction 
between public health risks of infection and different lifestyles 
may account for this gender difference. For example, a recent 
study conducted by Atre et al. (21) to examine community 
perceptions of TB-related stigma showed that concealment of 
a disease such as TB happened more among females because 
of fear of losing social status, marital problems, or harmful 
reactions from the community.
In the present study, a large number of the TB/HIV co-infected 
patients were in the 31–60 year age group (91.7%) with the 
mean age of 36.2 (±6.2) years and also were male. The fact that 
the highest occurrence was found in the 31–60 year age group 
suggests that the co-infected patients are individuals in the most 
productive phase of their life, which leads to economic losses 
and subsequently has social repercussions for patients, families, 
and society. These data are in agreement with those reported in 
the literature (14,22) which confirm that TB/HIV co-infection 
is more common in males.
There was a statistically significant difference between gender 
and age groups (P< 0.001). Codlin et al. (23) showed that highest 
number of notified TB cases are in the 15–34 year age groups 
in both males and females, disproportionately more in females. 
There are a number of reasons justifying the high  occurrence 
of TB in younger women compared to younger men; among 
others, adult women are more likely than adult men to have a 
close contact with TB patients because young women in this 
community mostly perform the nursing roles within the family. 
As shown in Table 2, the recent close contact with TB patients 
is more common in females than male (P= 0.018). Women are 
more likely than men to have strains in common with other 
patients (24). 
The results of this study revealed that being smear-positive and 
age of 60 years or more were the most important predictive 
components of reporting source type which could be used for 
planning TB program. On the other hand, public hospitals 
were more likely than public outpatient services to report both 
smear-positive cases and patients aged 60 years or more. But, 
there was no significant difference between reporting system 
in terms of gender. In this study, the public hospitals (50.2%), 
public outpatient services (27.1%), and private sector (17.8%) 
had the highest rate of reporting that is in concordant with other 
studies (6). Accordingly, the private system is one of the most 
effective sectors in TB program (25,26), but their involvement 
in reporting smear-positive TB is extremely less than public 
health system (as shown in Table 4). In another study performed 
by Masjedi et al. (27) to determine TB detection in the private 
sector in Tehran, 87.3% of TB cases have been diagnosed by the 
private sector. In that study, authors concluded that the private 
sector plays a significant role in TB detection, but there is poor 
cooperation and communication between the private and public 
health systems. Although, health insurance system in Iran, and 
even in rural areas, has a high coverage, the rate of reporting 
from this sector was 4.9%. As a result, involving the insurance 
organizations in TB program is necessary (6).
Limitations
This study was associated with a number of limitations. First, 
there probably is different sensitivity on diagnosis of extra 
Table 3. Trends of TB case-finding in Hamadan Province, 2005–11
TB classification
Expected number TB cases reported
%increasea C-A test
2005 2006 2007 2008 2009 2010 2011
Total population 1669870 1703267 1711783 1720342 1728944 1737589 1758268 - -
New TB cases (Total) 115 (3.4) 109 (3.2) 121 (3.6) 160 (4.7) 112(3.3) 151 (4.4) 252 (7.3) 56 <0.001
New smear-positive 73 (2.2) 73 (2.2) 89 (2.6) 114 (3.4) 81(2.4) 94 (2.8) 89 (2.6) 6 0.126
New smear-negative 10 (0.3) 10 (0.3) 8 (0.2) 18 (0.5) 20 (0.6) 43 (1.3) 81 (2.4) 30 <0.001
New extra pulmonary 32 (1.0) 26 (0.8) 24 (0.7) 28 (0.8) 12 (0.3) 14 (0.4) 82 (2.4) 20 <0.001
Age-adjusted prevalence 68 (4.1) 61 (3.6) 73 (4.3) 88 (5.1) 64 (3.7) 83 (4.9) 157 (8.5) 63 0.001
Values in parentheses are age-adjusted incidence per 100 000 people.
aannual rate of percent change in case finding during 2005–11.
Table 4. Comparison of age, gender and TB type in registered TB patients between different sources of TB reporting using Chi-square test
Variable
Source of reporting
Total (%)
PHO (%) PHS (%) Private (%) Social security (%)
Age
<60 year 62 (32.0) 88 (45.4) 35 (18.0) 9 (4.6) 194 (100)
>61 year 54 (23.1) 127 (54.3) 41 (17.5) 12 (5.1) 234 (100)
P-value - 0.029 0.316 0.371 -
Gender
Male 49 (24.1) 111 (54.7) 30 (14.8) 13 (6.4) 203 (100)
Female 67 (29.8) 104 (46.2) 46 (20.4) 8 (3.6) 225 (100)
P-value - 0.103 0.703 0.096 -
Type of TB
Smear-Positive 27 (15.3) 113 (63.8) 26 (14.7) 11 (6.2) 177 (100)
Non-positive* 89 (35.5) 102 (40.6) 50 (19.9) 10 (4.0) 251 (100)
P-value - 0.001 0.097 0.006 -
Total 116 (27.1) 215 (50.2) 76 (17.8) 21 (4.9) 428 (100)
Abbreviation: PHO; Public Health system Outpatient, PHS; Public Health System hospital, TB; Tuberculosis.
*Non-positive= smear-negative & extra pulmonary. *PHO considered as reference group.
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pulmonary and smear-negative cases because of different 
physicians. Second, diagnosis of extra pulmonary cases was 
usually done based on clinical diagnosis instead of biopsy. 
Third, 22% of source reporting (127 from 597 cases) was 
unknown. These issues may raise the possibility of information 
bias. Another limitation of this study was that the information 
of some variables such as HIV status and prison history of 
patients has not been directly investigated. Information about 
these factors was based on self-reported responses. Accordingly, 
self-report may again be a cause of potential information bias 
and underestimate real status of the variables. Notwithstanding, 
our study used a data with seven years period, the results may 
not be generalisable to the other areas.
Conclusion
Although, the incidence rate of TB in Hamadan Province is 
lower than country’s average, increasing trend of TB incidence is 
not concordant with its decreasing trend in Iran. Upward trend 
in HIV prevalence and the importance of TB co-infection with 
HIV as an alarm should  be considered. An epidemiological 
study is required to evaluate risk factors associated with TB to 
identify ways to decrease the prevalence of TB.
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Implications for policy makers
• Involving private sector in tuberculosis (TB) program 
is necessary due to high volume of private physicians 
practicing in Iran.
• As quality of data is very important in strengthening TB 
program performance, knowledge of TB coordinates 
should be improved. 
• The presence of the concurrently high HIV prevalence 
can be an alarm for policy-makers; as someone with HIV 
infection is much more likely to develop TB disease than 
someone without HIV infection.
• In the region under study, contrary to country’s average, 
the incidence of TB is increasing. This calls for future 
studies to identify factors associated with TB occurrence.
Implications for public
The results of our study showed that the incidence of 
tuberculosis is increasing. Therefore, there is a need for 
health education to inform public about the factors associated 
with TB disease including overcrowding, lack of knowledge, 
poverty, co-infection with HIV, and so on. Moreover, 
tuberculosis co-infection with HIV is one of the preventable 
causes of death. Accordingly, improving public awareness of 
HIV risk is urgently needed.
Key Messages 
